| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | CA2521619A1 Aminoquinoline compounds |
| 10/28/2004 | CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 10/28/2004 | CA2520804A1 Biaryl substituted pyrazoles as sodium channel blockers |
| 10/28/2004 | CA2520323A1 Tie-2 modulators and methods of use |
| 10/28/2004 | CA2520259A1 Cxcr4 chemokine receptor binding compounds |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1470137A1 Edg receptor agonists |
| 10/27/2004 | EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 10/27/2004 | EP1470119A1 Benzothiophene compounds having antiinfective activity |
| 10/27/2004 | EP1470113A1 Pyrimidinone viral polymerase inhibitors |
| 10/27/2004 | EP1469851A1 Melanocortin receptor agonists |
| 10/27/2004 | EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 10/27/2004 | EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 10/27/2004 | EP0970073B1 Process for preparing eprosartan |
| 10/27/2004 | CN1541259A Fluorescent diketopyrrolopyrrole analogues |
| 10/27/2004 | CN1541215A HIV inhibiting pyrimidines derivatives |
| 10/27/2004 | CN1541214A Novel compounds |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541203A 4-(phenyl-(piperidin-4-YL)-amino)-benzamide derivatives and their use for treatment of pain, anxiety or gastrointestinal disorders |
| 10/27/2004 | CN1539825A Compounds useful to treat retroviral infections |
| 10/27/2004 | CN1539816A IL-8 receptor antagonist |
| 10/27/2004 | CN1172917C Steroid receptor modulator compounds and methods |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection |
| 10/26/2004 | US6809102 For therapy of proliferative diseases, such as cancer; to interrupt mitosis |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809098 Compounds |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
| 10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 10/26/2004 | US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 10/26/2004 | CA2196263C Process for the preparation of 4-oxoimidazolinium salts |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/21/2004 | WO2004089940A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 10/21/2004 | WO2004089936A1 Heteroarylsulfonanilide derivative and medicinal composition containing the same |
| 10/21/2004 | WO2004089932A1 Substituted pyrazole compounds |
| 10/21/2004 | WO2004089931A1 Substituted pyrazoles |
| 10/21/2004 | WO2004089929A1 5-amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseases |
| 10/21/2004 | WO2004089918A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 10/21/2004 | WO2004089915A1 Piperazine derivative renin inhibitors |
| 10/21/2004 | WO2004089914A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 10/21/2004 | WO2004089913A1 Aminopyrimidine derivatives and their medical use |
| 10/21/2004 | WO2004089911A1 Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of alzheimer’s disease |
| 10/21/2004 | WO2004089910A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders |
| 10/21/2004 | WO2004089908A2 3-azabicyclo[3.2.1]octane derivatives |
| 10/21/2004 | WO2004089892A2 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
| 10/21/2004 | WO2004089529A1 Method for the intramolecular energy transfer for the cleavage of labile functional group from biomolecules and the protected biomolecules |
| 10/21/2004 | WO2004089367A1 Pharmaceutical use of substituted 1,2,4-triazoles |
| 10/21/2004 | WO2004089362A1 2-cyanopyrroles and their analogues as ddp-iv inhibitors |
| 10/21/2004 | WO2004089360A1 Polyamine compounds for treating chemokine receptor mediated diseases |
| 10/21/2004 | WO2004065380A8 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 10/21/2004 | WO2004056786A3 Pyrimidine derivates for the treatment of abnormal cell growth |
| 10/21/2004 | WO2004009556A9 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 10/21/2004 | WO1995018619A9 Bicyclic fibrinogen antagonists |
| 10/21/2004 | US20040209922 Pyridine matrix metalloproteinase inhibitors |
| 10/21/2004 | US20040209921 CXCR4 chemokine receptor binding comounds |
| 10/21/2004 | US20040209915 substituted with an N- (p-hydroxy-alpha-hydroxybenzylaminoalkylpiperidinyloxy- (or -amino-)carbonylamino group; useful for identifying compounds having both beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 10/21/2004 | US20040209912 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 10/21/2004 | US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 10/21/2004 | US20040209902 Aminoquinoline compounds |
| 10/21/2004 | US20040209895 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases |
| 10/21/2004 | US20040209889 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 10/21/2004 | US20040209883 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 10/21/2004 | US20040209882 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 10/21/2004 | US20040209881 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 10/21/2004 | US20040209880 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 10/21/2004 | US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 10/21/2004 | US20040209863 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents |
| 10/21/2004 | US20040209860 compounds having a (biphenyl-2-yl)oxycarbonylamino- or (biphenyl-2-yl)aminocarbonylamino-substituted (2-7C)azacycloalkyl or (5-10C)azabicycloalkyl group; and a 2-(4-hydroxyphenyl)-2-hydroxyethylamino group; treating asthma or chronic obstructive pulmonary disease; providing bronchodilation |
| 10/21/2004 | US20040209846 Heterocyclic analgesic compounds and methods of use thereof |
| 10/21/2004 | US20040209778 Lactone derivative, and plant growth regulator and rooting agent each containing the same as active ingredient |
| 10/21/2004 | US20040208822 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis |
| 10/21/2004 | CA2522023A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 10/21/2004 | CA2521830A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 10/21/2004 | CA2521416A1 Polyamine compounds for treating chemokine receptor mediated diseases |
| 10/21/2004 | CA2521400A1 Piperazine derivative renin inhibitors |
| 10/21/2004 | CA2521340A1 Aminopyrimidine derivatives and their medical use |
| 10/21/2004 | CA2521227A1 Substituted pyrazole compounds |
| 10/21/2004 | CA2521202A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders |
| 10/21/2004 | CA2521201A1 Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors |
| 10/20/2004 | EP1467978A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467975A1 Substituted alkyl uracils and the use thereof |
| 10/20/2004 | EP1467974A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 10/20/2004 | EP1467972A1 Indazole compounds useful as protein kinase inhibitors |
| 10/20/2004 | EP1467969A2 Dna minor groove binding compounds |
| 10/20/2004 | EP1467730A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 10/20/2004 | EP1467727A1 1,3-disubstituted and 1,3,3,-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 10/20/2004 | EP1261588B1 IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS |
| 10/20/2004 | EP1246619B1 Urotensin-ii receptor antagonists |
| 10/20/2004 | EP1204660B1 Serotonergic benzothiophenes |
| 10/20/2004 | EP1131291B1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 10/20/2004 | EP1109551A4 4-amino-3-mercapto-1,2,4-triazoles |
| 10/20/2004 | EP0830136B1 New cryptophycins from synthesis |